6-Benzothiazolyl Ureas, Thioureas and Guanidines are Potent Inhibitors of ABAD/17#946;-HSD10 and Potential Drugs for Alzheimer#34;s Disease Treatment: Design, Synthesis and in vitro Evaluation

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|13|4|345-358

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.13, Iss.4, 2017-05, pp. : 345-358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s disease

By Martinez Ana   Castro Ana  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 1, 2006-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite

GSK-3 inhibitors and their potential in the treatment of Alzheimer’s disease

By Kypta Robert M  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 10, 2005-10 ,pp. : 1315-1331

Informa Healthcare

Access to resources Recommend Favorite

Biological Evaluation of Halogenated Thioureas as Cholinesterases Inhibitors Against Alzheimer’s Disease & Molecular Modeling Studies

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 6, 2015-07 ,pp. : 488-494

Bentham Science Publishers

Access to resources Recommend Favorite

-Amyloid Disrupting Drugs: Potential in the Treatment of Alzheimer's Disease

By Soto C.  

CNS Drugs, Vol. 12, Iss. 5, 1999-11 ,pp. : 347-356

Adis International

Access to resources Recommend Favorite

Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease

By  

Current Neuropharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 239-255

Bentham Science Publishers

Access to resources Recommend Favorite